7,631
Views
60
CrossRef citations to date
0
Altmetric
Reports

Secukinumab, a novel anti–IL-17A antibody, shows low immunogenicity potential in human in vitro assays comparable to other marketed biotherapeutics with low clinical immunogenicity

, &
Pages 536-550 | Received 10 Jul 2015, Accepted 22 Dec 2015, Published online: 04 Mar 2016